Pegevongitide

Pegevongitide is an agonist of the angiopoietin-1 receptor.

2988012-71-9

AV-001

12352209

ANGPTL

Metabolic Enzyme/Protease

Neuroscience-Neuromodulation

Cardiovascular Disease

99.31

DMSO : 66.67 mg/mL (ultrasonic)

O=C(N[C@@H](CC1=CNC=N1)C(N[C@@H](CC2=CNC=N2)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC3=CNC=N3)C(N[C@@H](CO)C(N[C@@H](CC4=CC=CC=C4)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC5=CNC=N5)NC(CCSCC(NCCOCCC(CCOCCNC(CSCCC(N[C@@H](CC6=CNC=N6)C(N[C@@H](CC7=CNC=N7)C(N[C@@H](CC8=CNC=N8)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC9=CNC=N9)C(N[C@@H](CO)C(N[C@@H](CC%10=CC=CC=C%10)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)(CCOCCNC(CSCCC(N[C@@H](CC%11=CNC=N%11)C(N[C@@H](CC%12=CNC=N%12)C(N[C@@H](CC%13=CNC=N%13)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC%14=CNC=N%14)C(N[C@@H](CO)C(N[C@@H](CC%15=CC=CC=C%15)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CCOCCNC(CSCCC(N[C@@H](CC%16=CNC=N%16)C(N[C@@H](CC%17=CNC=N%17)C(N[C@@H](CC%18=CNC=N%18)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC%19=CNC=N%19)C(N[C@@H](CO)C(N[C@@H](CC%20=CC=CC=C%20)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O.[n]

14600 (Approximately)

[1]WHO Drug Information. Volume 38, No. 2.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10887/

Peptides

No Development Reported